🔗 Permalink

Inventor profile of:

Andrew Lees

City:

Silver Spring, Maryland

Country:

United States

Published Applications:

26

Last publication date:

2023-08-03

Top Assignees for applications by Andrew Lees

The entities that hold a legal rights for patent applications filed by inventor Lees Andrew:

Fina BioSolutions, LLC 13 Rockville, MD United States
BIOSYNEXUS INCORPORATED 5 Gaithersburg, MD United States
The United States of America as Represented by the Secretary of the Army 2 Washington, DC United States
FinaBioSolutions, LLC 1 Rockville, MD United States
Biosynexus, Inc. 1 Gaithersburg, MD United States
SERUM INSTITUTE OF INDIA LTD. 1 Pune, India
Henry M. Jackson Foundation for the Advancement of Military Medicine 1 Rockville, MD United States
FFINA BIOLUTIONS, LLC 1 Silver Spring, MD United States
The Forsyth Institute 1 Boston, MA United States
Fina Bio Solutions ,LLC 1 Silver Spring, MD United States

Recent patent applications by Lees Andrew

Andrew Lees from Silver Spring, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-08-03

US20230242961A1

Chemistry; metallurgy

Production of Soluble Recombinant Protein

#2 | 2023-04-20

US20230122876A1

Human necessities

Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines

#3 | 2021-11-11

US20210348174A1

Chemistry; metallurgy

Production of soluble recombinant proteins without N-terminal methionine in

#4 | 2020-07-09

US20200216872A1

Chemistry; metallurgy

Production of soluble recombinant protein without n-terminal methionine

#5 | 2019-01-31

US20190032063A1

Chemistry; metallurgy

Expression and purification of CRM proteins and related proteins, and protein domains

#6 | 2016-11-17

US20160333057A1

Chemistry; metallurgy

Expression and purification of CRM197 and related proteins

#7 | 2014-10-30

US20140323688A1

Human necessities

Activation of polysaccharides via the cyanylating agent, 1-cyanobenzotriazole (1-CBT), in the preparation of polysaccharide/protein conjugate vaccines

#8 | 2014-10-23

US20140316111A1

Human necessities

Activation of polysaccharides via the cyanylating agent, 2-cyanopyridazine-3(2H)-one (2-CPO), in the preparation of polysaccharide/protein conjugate vaccines

#9 | 2014-10-23

US20140316110A1

Human necessities

Activation of polysaccharides via the cyanylating agent, 1-cyanoimidazole (1-Cl), in the preparation of polysaccharide/protein conjugate vaccines

#10 | 2014-07-03

US20140186388A1

Human necessities

Method for Producing Protein-Carbohydrate Vaccines Reduced in Free Carbohydrate

#11 | 2013-11-14

US20130302877A1

Chemistry; metallurgy

Differential Functionalization of Polymers with Amino-Oxy Reagents for Diagnostic Assays

#12 | 2013-02-28

US20130052204A1

Human necessities

(POLY)-GLYCEROLPHOSPHATE-BASED ANTI-GRAM POSITIVE BACTERIAL VACCINE

#13 | 2012-11-15

US20120288518A1

Human necessities

Activation of polysaccharides via the cyanylating agent, 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), in the preparation of polysaccharide/protein conjugate vaccines

#14 | 2012-08-23

US20120214187A1

Method for Enhancing the Sensitivity of Antibody Based Assays

#15 | 2012-05-31

US20120135030A1

Human necessities

Method of producing protein-carbohydrate vaccines reduced in free carbohydrate

#16 | 2011-10-27

US20110263834A1

Chemistry; metallurgy

Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels

#17 | 2009-03-26

US20090081180A1

Human necessities

ANTIMICROBIAL POLYMER CONJUGATES

#18 | 2008-11-18

US10403223

Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol

#19 | 2008-01-24

US20080019976A1

Chemistry; metallurgy

Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria

#20 | 2007-12-20

US20070292404A1

Human necessities

Antimicrobial polymer conjugates

#21 | 2007-07-31

US10323927

Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria

#22 | 2006-09-05

US9562328

Conjugate vaccines for the prevention of dental caries

#23 | 2006-08-22

US8905046

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

#24 | 2005-08-04

US20050169941A1

Human necessities

Use of amino-oxy functional groups in the preparation of protein-polysaccharide conjugate vaccines

#25 | 2005-04-07

US20050075486A1

Chemistry; metallurgy

Monoclonal antibody which agglutinates having the CS4-CFA/I family protein

#26 | 2005-04-07

US20050074460A1

Human necessities

Process for preparing conjugate vaccines and the conjugate vaccines

InventorID:

113623 ⎘